Birdwatch Note
2024-11-28 20:19:56 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
Written by 454118980193F7277AFB3F7E7ED8985C8D8EBC08467C2D4D4E2FB20181EABE33
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1861974678593790246
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1862229962469658685
- noteId - 1862229962469658685
- participantId -
- noteAuthorParticipantId - 454118980193F7277AFB3F7E7ED8985C8D8EBC08467C2D4D4E2FB20181EABE33
- createdAtMillis - 1732825196269
- tweetId - 1861974678593790246
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
Note Ratings
| rated at | rated by | |
| 2024-11-29 17:12:53 -0600 | Rating Details | |
| 2024-11-29 11:06:33 -0600 | Rating Details | |
| 2024-11-29 07:28:52 -0600 | Rating Details | |
| 2024-11-29 05:27:34 -0600 | Rating Details | |
| 2024-11-29 00:15:03 -0600 | Rating Details | |
| 2024-11-28 23:01:42 -0600 | Rating Details | |
| 2024-11-28 22:24:32 -0600 | Rating Details | |
| 2024-11-28 21:58:31 -0600 | Rating Details | |
| 2024-11-28 21:50:25 -0600 | Rating Details | |
| 2024-11-28 21:36:05 -0600 | Rating Details | |
| 2024-11-28 21:35:32 -0600 | Rating Details | |
| 2024-11-28 21:32:58 -0600 | Rating Details | |
| 2024-11-28 21:31:35 -0600 | Rating Details | |
| 2024-11-28 20:53:51 -0600 | Rating Details | |
| 2024-11-28 20:47:02 -0600 | Rating Details | |
| 2024-11-28 20:46:43 -0600 | Rating Details | |
| 2024-11-28 20:38:50 -0600 | Rating Details | |
| 2024-11-28 20:32:08 -0600 | Rating Details | |
| 2024-11-28 20:18:57 -0600 | Rating Details | |
| 2024-11-28 20:03:56 -0600 | Rating Details | |
| 2024-11-28 19:58:23 -0600 | Rating Details | |
| 2024-11-28 19:45:31 -0600 | Rating Details | |
| 2024-11-28 19:38:35 -0600 | Rating Details | |
| 2024-11-28 19:22:55 -0600 | Rating Details | |
| 2024-11-28 18:49:14 -0600 | Rating Details | |
| 2024-11-28 16:36:57 -0600 | Rating Details | |
| 2024-11-28 14:44:09 -0600 | Rating Details | |
| 2024-11-29 00:47:52 -0600 | Rating Details | |
| 2024-11-28 22:37:20 -0600 | Rating Details | |
| 2024-11-28 22:11:38 -0600 | Rating Details | |
| 2024-11-28 22:04:48 -0600 | Rating Details | |
| 2024-11-28 22:00:06 -0600 | Rating Details | |
| 2024-11-28 21:48:22 -0600 | Rating Details | |
| 2024-11-28 21:35:37 -0600 | Rating Details | |
| 2024-11-28 21:16:21 -0600 | Rating Details | |
| 2024-11-28 21:12:42 -0600 | Rating Details | |
| 2024-11-28 21:09:00 -0600 | Rating Details | |
| 2024-11-28 21:02:31 -0600 | Rating Details | |
| 2024-11-28 20:58:59 -0600 | Rating Details | |
| 2024-11-28 20:54:38 -0600 | Rating Details | |
| 2024-11-28 20:53:46 -0600 | Rating Details | |
| 2024-11-28 20:52:47 -0600 | Rating Details | |
| 2024-11-28 20:44:16 -0600 | Rating Details | |
| 2024-11-28 20:34:00 -0600 | Rating Details | |
| 2024-11-28 20:30:47 -0600 | Rating Details | |
| 2024-11-28 20:30:19 -0600 | Rating Details | |
| 2024-11-28 22:49:59 -0600 | Rating Details | |
| 2024-11-28 21:32:18 -0600 | Rating Details | |
| 2024-11-28 21:26:22 -0600 | Rating Details | |
| 2024-11-28 21:22:47 -0600 | Rating Details | |
| 2024-11-28 21:03:23 -0600 | Rating Details | |
| 2024-11-28 21:00:12 -0600 | Rating Details | |
| 2024-11-28 20:44:39 -0600 | Rating Details | |
| 2024-11-28 20:29:23 -0600 | Rating Details | |
| 2024-11-28 20:09:27 -0600 | Rating Details | |
| 2024-11-28 18:53:01 -0600 | Rating Details | |
| 2024-11-28 18:49:03 -0600 | Rating Details | |
| 2024-11-28 18:41:16 -0600 | Rating Details | |
| 2024-11-28 17:21:33 -0600 | Rating Details | |
| 2024-11-28 16:42:12 -0600 | Rating Details | |
| 2024-11-28 16:22:59 -0600 | Rating Details | |
| 2024-11-28 15:19:48 -0600 | Rating Details | |
| 2024-11-28 14:35:22 -0600 | Rating Details | |
| 2024-11-28 14:21:27 -0600 | Rating Details |